Author

Saikat Boliar

Cornell UniversityORCID 0000-0002-3340-5368Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

David G. RusselliD· 2 shared David W. GludishiD· 2 shared Gabrielle Lê-BuryiD· 2 shared Christine Mandalasi· 1 shared Godwin Akpeko DziwornuiD· 1 shared Grace MugumbateiD· 1 shared Henry Charles MwandumbaiD· 1 shared Jonathan T. BvunzawabayaiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

David G. RussellORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Screening of epigenetic modifiers identifies novel host-directed agents that suppress HIV-1 replication in primary human macrophages

Gabrielle Lê-Bury, Christine Mandalasi, Jordan M. Rhen, David W. Gludish, Saikat Boliar, Henry Charles Mwandumba, David G. Russell

This study identifies novel compounds that inhibit HIV-1 replication in primary human macrophages by targeting epigenetic regulators.

bioRxiv · Sep 4, 2026 · PreprintImmunology

Accessing anti-HIV activity through the attenuation of USP18 activity: novel insights from molecular dynamic simulations, free-energy profiling, and multi-cellular inhibition assays

Lester Takunda Sigauke, Jonathan T. Bvunzawabaya, Gabrielle Lê-Bury, Godwin Akpeko Dziwornu, Saikat Boliar, David W. Gludish, David G. Russell, Krishna Kuben Govender, Grace Mugumbate, Nyaradzo T. L. Chigorimbo‐Murefu

This study explores using USP18 inhibition to achieve anti-HIV activity through molecular simulations, free-energy profiling, and multi-cellular assays, showing reversible non-competitive inhibition and potential for antiviral strategies.

bioRxiv · Jun 23, 2024 · PreprintImmunology